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INTRODUCTION
The antibody response requires the participation of bursa-equivalent organ-derived lympho-
cytes (B-cells), whose progeny are antibody-forming cells (AFC); thymus-derived lymphocytes
(T-cells); and macrophages or their chemical surrogates 6 ,9,16,28). In contrast, cell-mediated
immunity is based on functions of effector T -cells and macrophages or their chemical medi-
ators 4 ,5,20,23). To clarify cellular mechanisms involving in these phenomena, many adjuvants
have been used as immunological tools. Recently, it has been clarified that mycobacterial water-
soluble fractions can be substituted for heat-killed tubercle bacilli in Freund's complete adjuvant
(FCA)1,12,18,19,22,28). These water-soluble fractions, which probably share common chemical
structure indispensable for the adjubant activity is a structural unit, M urNAc-L-Ala-D-isoGln,
of the peptidoglycans8,17).
The adjuvant activity of water-soluble fractions has been demonstrated by the enhancement
of antibody responses, especially IgG2 antibody response and delayed type hypersensitivity
(DTH) induction against ovalbumin (OA) antigens in guinea pigs18). Little is known, however,
about the adjuvant effects of these fractions on immune responses against the hapten-carrier type
of antigens 2). In the present paper, the authors describe the adjuvant effects of a mycobacterial
water-soluble adjuvant, MAF3, on the humoral and cellular immune responses of guinea pigs to
dinitrophenol (DNP) conjugated with different carriers: bovine serum albumin (BSA), oval-
bumin (OA), guinea pig serum albumin (GPA), dextran, and MAF3.
MATERIALS AND METHODS
Animals. Adult Hartley guinea pigs, weighing 300 to 500 g, were used in all experiments.
* Part of this experiment was reported in a short communication elsewhere30>.
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They were housed in the same room and fed with laboratory chow, fresh cabbage and water ad
libitum.
Antz"gens and adjuvants. OA (INC Pharmaceuticals, Inc., Ohio), BSA (Seikagaku Kogyo
Co., Tokyo), Dextran T2000 (Pharmacia Fine Chemicals, Sweden) and s-N-DNP-Lysine (DNP-
Lys) (Tokyo Chemical Industry, Tokyo) were commercially available. GPA was prepared from
guinea pig serum as Chon's fraction V. MAF3 was prepared from the delipidated cells of
Mycobacterium tuberculosis strain Aoyama B by hydrogenolysis and gel filtration as described
elsewhere18) • This was adjuvantogenic in the immunization of guinea pigs with heterologous
proteins and a heteropolymer(s) consisting of approximately 76 to 79% mucopeptide. The car-
rier proteins described above were conjugated with DNP by the method of Eisen?>, and the ratio
of DNP to protein in the conjugates was calculated after removal of unconjugated DNP by gel
filtration on a Sephadex G-25 column. Protein was measured by Lowry's method, and DNP
was estimated by absorption at E 360 nm. Dextran was conjugated with DNP-Lys with the use
of cyanuric chloride (Wako Pure Chemical Industry, Tokyo) 11>. The amount of DNP coupled
to OR-groups of dextran was calculated from its weight and absorption at E 360 nm, and the
polysaccharide was measured by the anthrone method 25 >. Thus, the DNP numbers conjugated
to a carrier molecule were estimated as follows: DNP13-BSA, DNP15-0A, DNP31-dextran,
DNPs-GPA and DNPo. 1-MAF3.
Immunization. An aqueous solution of one of the antigens with or without MAF3 was
mixed with an equal volume of Frend's incomplete adjuvant (FIA) (Difco Laboratories, Michigan)
and injected into the hind footpads of guinea pigs. Each animal received 10, 100, or 1,000 f-tg
of the antigen with or without 100 f-tg of MAF3.
Serological test and DTH reaction. At the intervals shown in the figures, blood was drown
by heart puncture, and the serum was separated. DNP-OA was conjugated to sheep erythro-
cytes (SRBC) by the chromium (III) chloride method1o>, and the DNP-SRBCs were subjected
to passive hemolysis in the presence of immune sera and guinea pig complement. Anti-DNP
antibodies were titrated as a function of Log 2. Skin reactions to DTH were tested by the intra-
cutaneous injection of 100 f-tg (0.1 ml) of an antigen 6 weeks after immunization, and the area
of local erythema was measured 48 hours later. The corneal reaction was tested simultaneously
as described previouslyls>. Briefly, a small amount of DNP-BSA or other antigen solution
(20 f-tg!ml), enough to make a transient opaque disc approximately 5 mm in diameter in the
cornea, was carefully injected intracorneally and the opacity was inspected 48 h later. The
degree of opacity was graded: strong, 3; moderate, 2; weak, 1; or negative, O.
RESULTS
Effect of M AF3 on immune response to hapten conjugated with T-cell dependent carrier
antigen. The adjuvant activity of MAF3 on anti-hapten antibody production and DTH induc-
tion was investigated in guinea pigs immunized with DNP-BSA. As shown in Fig. 1, no anti-
DNP antibody was detectable one week after the immunization either with or without the con-
comitant use of MAF3. However, on and after the second week, the antibody production increas-
ed markedly. The response reached a maximum in the third week and continued through the
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Fig. 1 Adjuvant effect of MAF3 on anti-DNP antibody response of guinea pigs
after immunization with 100 /Lg DNP-BSA in FlA. [01 DNP-BSA+
MAF3, [e1 DNP-BSA alone.
Fig. 2 Adjuvant effect of MAF3 on induction of delayed type skin reaction in
guinea pigs after immunization with 100 /Lg of DNP-BSA. [0] DNP-
BSA+MAF3, [e] DNP-BSA alone. Challenging antigens: 100/Lg of
DNP-BSA, 100 /Lg of DNP-OA, and 100 /Lg of BSA. The diameter of
erythema was measured 48 h after intracutaneous challenge with these
antigens. Each dot shows arithmetic mean±standard deviation (SD)
(5 animals/group).
seventh week. The antibody production was always greater in animals immunized with DNP-
BSA plus MAF3 than in the immune controls.
DTH reactions in these animals were examined by delayed skin reaction to DNP-BSA,
DNP-OA or BSA, as shown in Fig. 2. When conducted with DNP-BSA, the reaction appeared
in all the immune animals, and it was markedly stronger in those treated with the antigen plus
MAF3 than in those given antigen alone. When DNP-OA was employed as the challenging
antigen, the reaction resembled that caused by DNP-BSA, except that the area of erythema was
much smaller. When challenged with BSA, no reaction occurred in animals immunized with
the antigen alone, and a moderate reaction in those immunized with the antigen plus adjuvant.
As a rule, animals immunized with the hapten-carrier antigen plus adjuvant showed stronger
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Table. 1 Adjuvant effect of MAF3 on induction of delayed corneal reaction in guinea
pigs immunized with DNP-BSA in FIA
Challengeda J Strength of corneal reactionImmunized with -----_ ..- ._-~------~~----_..._-
with 1 2 3 4 6 8
week
--- - --------_.------ ---_._--------- ~ ._-----------
DNP-BSA+MAF3 DNP-BSA 0.5bJ 2.4 2.5 2.6 2.4 3.0
DNP-BSA alone II 0 0.2 0 0.1 0.2 0
DNP-BSA+MAF3 BSA 0 1.2 1.0 0.4 0.1 0
DNP-BSA alone II 0 0 0 0 0 0
aJ Guinea pigs were intracorneally injected with the antigen making a transient opaque disc
approximately 5 mm in diameter.
bJ Each number shows the arithmetic mean calculated from the results of 5 animals per group.
3, strong; 2, moderate; 1, weak; and 0, negative.
reactions to the hapten or the carrier than did those immunized with the conjugates alone. Fur-
thermore, the adjuvant activity of MAF3 was confirmed by the corneal test, as shown in Table l.
The reaction was negative or minimal in guinea pigs immunized with DNP-BSA alone, while
those immunized with DNP-BSA plus MAF3 showed positive reactions. DNP-BSA evoked
stronger reactions in these animals than did BSA.
Effect of MAF3 on immune response to hapten conjugated with a T-cell independent carrier
antigen. Whether MAF3 was given or not, guinea pigs immunized with 10 or 100 fLg of DNP-
dextran showed no detectable anti-DNP antibody response during the 5 weeks after immuniza-
tion. No antibodies were detected after immunization with 1,000 fLg of this conjugate either,
but the concomitant use of MAF3 evoked an anti-DNP antibody response in these animals, as
illustrated in Fig. 3. These findings show that MAF3 is adjuvant-active with T-cell independent
antigen in producing anti-hapten anti-bodies when a large amount of the antigen is given at the
time of immunization.
DTH reactions did not appear in any of these animals immunized either with or without the
adjuvant. Both dermal and corneal reactions were negative. This probably means that effector
T -cells triggering DTH reactions could not be generated in guinea pigs immunized with the T-
cell independent antigen even if given together with the adjuvant.
Effect of MAF3 on the immune response to hapten conjugated wzih homologous protein.
The kinetics of anti-DNP antibody response in the guinea pig was studied during a 5-week period
after immunization with 10, 100 or 1,000 fLg of DNP-GPA. The data obtained are shown in
Fig. 4. In animals immunized with 10 or 100 fLg of DNP-GPA alone, antibody appeared during
the first week after immunization. The antibody response reached a maximum in the third week
and continued through the fifth week. No definite dose response was noted. The adjuvant
activity of MAF3 in the antibody response was recognized. After 1,000 fLg of the antigen, how-
ever, the antibody response was delayed and suppressed, and there was very little adjuvant effect
of MAF3.
When DTH reaction was examined in the skin 6 weeks after the immunization, the adjuvant
effect of MAF3 was clearly demonstrated in the DNP-GPA immune animals, as shown in Table
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Weeks after immunization
Adjuvant effect of MAF3 on anti-DNP
antibody response of guinea pigs after
immunization with DNP-GPA in FlA.
[0] 10 p,g of DNP·GPA+MAF3, [e] 10
p,g of DNP-GPA alone, [0] 100 p,g of
DNP-GAP+MAF3, [_] 100 JLg of DNP-
GPA alone, [~] 1,000 JLg of DNP-GPA+
MAF3, [A] 1,000 p,g of DNP-GPA alone.
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Adjuvant effect of MAF3 on anti-DNP
antibody response of guinea pigs after
immunization with 1,000 p,g of DNp·
dextran in FlA. [0] DNP-dextran +










. " >. 8










Table. 2 Adjuvant effect of MAF3 on induction of delayed skin reaction of guinea pigs
immunized with DNP-GPA in FIA
Erythema (mm in diameter)al
Immunized with
DNP-GPA DNP-OA DNP-Lys
10 p,g of DNP-GPA+MAF3 9. O±O. 7b > 4. 2±4. 8 0
10 p,g of DNP-GPA alone 5.8±0.7 5. 3±4. 7 a
100 p,g of DNP-GPA+MAF3 21. 7±2. 0 8.1±1. 7 a
100 JLg of DNP-GPA alone 8.1±0.4 a a
1,000 p,g of DNP-GPA+MAF3 4. 2±4. 9 a 0
1,000 p,g of DNP-GPA alone a 0 0
a) Skin tests were conducted 6 weeks after immunization and erythemas provoked were measured
in diameter 48 h after challenging injection.
b) Arithmetric means ±SD (5 animals/group)
2. However, little or no detectable reaction was induced after a high dose (1,000 fLg) of this anti-
gen, despite the concomitant use of the adjuvant. When challenged with DNP-OA, only animals
immunized with 100 fLg of this antigen fortified by additional MAF3 showed a delayed reaction.
The challenge injection with DNP-Lys did not provoke any delayed reaction even when the ad-
juvant had been used.
Effect oj'MAF3 on the immune response to hapten conjugated with MAF3. The anti-DNP
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Table. 3 Anti-DNP antibody response and DTH reaction in guinea pigs immunized with
DNP-MAF3 in FIA
Immunized Anti-DNP titer
a) Erythema (mm in diameter)bJ
with
----_._~--- --------------- --~--"-~----_..





DNP-MAF3 20 fLg 0 0.8±1.8 0 0 0 0 NDdJ
II 100 2.1±1.8 5. 2±O. 8 0 0 trace 12. 5±2. 3 ND
II 500 7.1±1.1 7.0±0 0 0 trace 15.1±2.5 ND
MAF3 100 0 0 0 0 0 0 13. 3±2. 3
aJ Passive hemolysis titer in Log 2. Arithmetric means±SD (% or 10 animals/group).
b) Skin erythema size measured in diameter 48 h after challenging injection. Arithmetric means ±
SD (5 animals/group).
cJ Challenging antigens (100 fLg, each) was injected intracutaneously into the flank of guinea pigs 6
weeks after immunization.
d) Not done
antibody response of guinea pigs was studied on the second and fifth week after an injection of
20, 100 or 500 fLg of DNP-MAF3 (Table 3). Immunization with 20 fLg of this antigen complex
produced no detectable anti-DNP antibody in the second week and a low antibody titer in the
fifth week. After 100 or 500 fLg, animals showed obvious anti-DNP antibody response in both
the second and fifth weeks. These findings indicate that MAF3 coupled to DNP is capable of
playing the roles of both carrier and adjuvant.
Table 3 also shows the dermal DTH reaction in these animals after an injection with one of
the antigens, DNP-Lys, DNP-OA, DNP-GPA, or DNP-MAF3. After challenge with the
former three antigens, no positive reaction was demonstrated. When immunized with a large
amount (100 fLg or over) of DNP-MAF3 and challenged with the same antigen complex, obvious
DTH reactions were observed. The reactions are likely to be considered to be due to the anti-
genicity of the carrier, because similar reactions were evoked by challenging injections of animals
immunized with the carrier alone, as is also shown in the table. One may note the insufficient
substitution of the antigenic sites of the acrrier with the hapten, as far as DNP-MAF3 is concerned.
DISCUSSION
When guinea pigs were immunized with a hapten-carrier type of antigen, DNP-BSA, in FIA,
anti-hapten antibodies were demonstrable in immune sera 2 weeks after the treatment. Con-
comitant use of MAF3 enhanced the antibody response strikingly. This means that MAF3 is
capable of stimulating the generation of hapten-specific B-cells and/or carrier-specific helper T-
cells in the guinea pig. On the other hand, immunization with any amount of DNP-dextran
alone could not raise the antibody response, while the response was seen only when 1,000 fLg of
this antigen plus 100 fLg of MAF3 was used. DNP-dextran is known as one of the T-cell inde-
pendent antigens in mice 23>. Although the thymic independence of this antigen has not been
clearly demonstrated in the guinea pig as yet, this may be possible as no cellular immunity to this
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antigen could be induced, as noted above. Thus the adjuvant activity of MAF3 in the induction
of anti-hapten antibodies in the guinea pig works on B-cells, without any help of T-cell activity,
directly through B-cell stimulation 19) or indirectly through macrophage activation 23 ,24,26).
Guinea pigs immunized with DNP-GPA could produce anti-DNP antibodies. This is be-
cause carrier-specific T -cells could recognize new antigenic determinants formed by coupling
DNP with homologous proteins 28). lVIAF3 was capable of enhancing the anti-hapten antibody
response, when given with a low does (10 or 100 J-tg) of this antigen complex. However, treat-
ment with a high does (1,000 J-tg) seemed to induce partial tolerance to the antigen, and the con-
comitant use of MAF3 could not destroy this tolerance.
The adjuvant effect of l\1AF3 on T-cells could be detected in DTH reactions. The animals
immunized with DNP-BSA or -GPA plus :lVIAF3 showed markedly stronger DTH reactions in
the skin and/or cornea than those immunized with the antigen alone. Levine 21 ) has reported that
if immunized animals are challenged with the carrier itself or hapten coupled to different carrier
proteins, the DTH reactions appear weaker than those induced by the sensitizing antigen. This
finding is supported by the data obtained in the present experiments. Delayed skin reactions
caused by BSA or DNP-OA in DNP-BSA immunized animals and by DNP-OA and DNP-Lys
in DNP-GPA immunized animals were negligible and were enhanced by the concomitant use of
MAF3 at the time of immunization. Moreover, no response was seen to a challenging injection
of DNP-Lys, the lysine moiety being a poor carrier under these conditions. These results indicate
that in the development of DTH, ]\1AF3 is capable of enhancing the generation of the effector
T -cells and that the effectors can repond not only to the hapten but also to the carrier.
Immunization with DNP-lYIAF3 raised the anti-hapten antibody response in guinea pigs,
but could not generate hapten-reactive effector T-cells. Positive skin reactions to DNP-MAF3
or MAF3 alone in animals immunized with DNP-MAF3 seemed to be due to the establishment
of immunity to the carrier antigen. Janeway et aP3,14,15). have reported that immunization with
DNP-H37 can generate hapten-reactive effector T-cells which are capable of reacting with the
hapten coupling to different carriers. The reason for the discrepancy between our results and
those of Janeway et al. is not clear as yet, but it is possible that it depends on the difference of
substitution rates of antigenic sites on carrier antigens with the hapten, DNP.
SUMMARY
The concomitant use of a mycobacterial water-soluble adjuvant, MAF3, at the time of im-
munization, enhanced anti-hapten antibody production in guinea pigs treated with either hetero-
logous or homologous dinitrophenylated proteins. This may be due to stimulation by the adju-
vant of B-cells and/or helper T-cells. The adjuvant activity of MAF3 in anti-hapten antibody
production was seen in immunization with a T-independent antigen, DPN-dextran, although it
appeared only when a large amount of the conjugated antigen was introduced as the immunizing
antigen. Delayed hypersensitivity reactions which require the participation of effector T-cells
were also increased by MAF3. When challenged with the same dinitrophenylated protein anti-
gen as the immunizing antigen, the delayed reactions in the skin or cornea were much stronger
in animals treated with the antigen plus adjuvant than in control immune animals. The enhance-
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ment was seen when T-dependent but not T-independent antigen was used together with the
adjuvant at immunization. No delayed hypersensitivity reaction was demonstrated after immuni-
zation with DNP-dextran either with or without MAF3.
Conjugates of DNP with MAF3 were immunogenic III the production of anti-DNP anti-
bodies in guinea pigs. However, delayed skin reaction in the these animals were induced by
challenging injections of the same conjugates as the immunizing antigen or MAF3, the carrier,
but not of DNP-GAP, DNP-OA or DNP-Lys. Similar skin reactions were observed in guinea
pigs immunized with MAF3 and challenged with the same antigen. Therefore, DNP-MAF3
is defective as a hapten-carrier antigen presumably because of insufficient substitution of antigenic
sites of the carrier with the hapten.
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